Clinical updates, including trial initiations, enrollment status and data readouts and publications: 23andme, AB, Ambrx, Atom, Cidara, CSL, Deciphera, Emalex, Imcyse, Iveric, Kancera, Karolinska, Lumos, Merck & Co., Moleculin, PDS, Tachyon.